JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ingham, C. J.
Right arrow Articles by Smith, M. C.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ingham, C. J.
Right arrow Articles by Smith, M. C.M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 36, Issue of September 6, 1996 pp. 21803-21807
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Isolation and Sequencing of the rho Gene from Streptomyces lividans ZX7 and Characterization of the RNA-dependent NTPase Activity of the Overexpressed Protein*

(Received for publication, March 6, 1996, and in revised form, May 22, 1996)

Colin J. Ingham Dagger §, Iain S. Hunter Dagger and Margaret C. M. Smith par

From the Dagger  Division of Molecular Genetics, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, G12, United Kingdom and the par  Department of Genetics, Queens Medical Centre, Nottingham University, Nottingham, NG7 2UH United Kingdom

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

The gene for transcription termination factor Rho was isolated from Streptomyces lividans ZX7. It encoded a 77-kDa polypeptide (Rho 77) with considerable homology to known Rho factors. An atypical hydrophilic region of 228 residues was found within the N-terminal RNA-binding domain. Only Rho from Micrococcus luteus and Mycobacterium leprae (closely related GC-rich Gram-positive bacteria) had an analogous sequence. Rho 77 was overexpressed in Escherichia coli and purified using an N-terminal hexahistidine-tag. Rho 77 displayed a broad RNA-dependent ATPase activity, with poly(C) RNA being no more than 4-fold more effective than poly(A). This contrasts with the ATPase activity of Rho from E. coli which is stimulated primarily by poly(C) RNA. Rho 77 was a general RNA-dependent NTPase, apparent Km values for NTPs were: GTP 0.13 mM, ATP 0.17 mM, UTP 1.1 mM, and CTP >2 mM. Rho 77 poly(C)-dependent ATPase activity was inhibited by heparin, unlike the E. coli Rho. The antibiotic bicyclomycin inhibited the in vitro RNA-dependent ATPase activity of Rho 77, did not inhibit growth of streptomycetes but delayed the development of aerial mycelia. N-terminal deletion analysis to express a truncated form of Rho (Rho 72, 72 kDa) indicated that the first 42 residues of Rho 77 were not essential for RNA-dependent NTPase activity and were not the targets of inhibition by heparin or bicyclomycin.


INTRODUCTION

The essential Escherichia coli transcription factor Rho mediates 3' end point formation in RNA by termination at specific sites. Rho uses a primary RNA binding activity, located in the N-terminal RNA-binding domain, which associates with single-stranded, cytidine-rich RNA. Termination by Rho involves the hydrolysis of ATP (or other NTP) coupled with secondary RNA-binding interactions to translocate the protein along RNA, toward the RNA 3' end and the paused RNA polymerase (reviewed in Refs. 1 and 2). Termination appears to be effected during this process by the RNA:DNA helicase activity of Rho (3). Rho-dependent terminators can be masked by the presence of ribosomes during translation and one major function of Rho may be to terminate untranslated mRNAs (4).

Recently, it has become apparent that the rho gene is widely distributed within the eubacteria (5, 6). Western blotting has detected the expression of Rho in a variety of Gram-negative bacteria (7). Only in the Mollicute Mycoplasma genitalium is a close Rho analogue apparently absent (8). However, there has been little characterization of Rho factor outside the enteric bacteria and a non-enteric Rho-dependent terminator has not been found. As the primary RNA binding activity of Rho shows a preference for C-rich RNA; it might be expected that Rho from an organism with an extreme GC content has an altered RNA binding specificity. We chose streptomycetes to address this question because of their extreme GC-rich bias, industrial importance as antibiotic producers, and because the role of Rho in Gram-positive bacteria is poorly defined. Here we report the isolation and sequencing of the rho gene from Streptomyces lividans. The protein has an extended RNA-binding domain which appears characteristic of Rho from GC-rich Gram-positive bacteria. The RNA-dependent NTPase activity of the overexpressed S. lividans Rho reveals significant differences to the enteric Rho which may relate to the GC-rich nature of target RNA.


MATERIALS AND METHODS

General DNA Manipulations

Transformation, purification, and manipulations of E. coli and streptomycete DNA were as described by Sambrook et al. (9) and Hopwood et al. (10), respectively. Purification of streptomycete genomic DNA was by the method of Hunter (11).

PCR1 Amplification of the Streptomyces Rho

Degenerate oligonucleotide primers were designed using conserved regions of ATPase domains of Rho (Fig. 1 and Ref. 6). These oligos were used to amplify a single band from 200 ng of mechanically sheared, heat-denatured genomic S. lividans ZX7 DNA (12) using 35 cycles of 94 °C, 50-55 °C, 72 °C (1.5 min at each temperature) followed by one cycle of 72 °C for 3 min. PCR used Promega Taq polymerase and buffers containing 1.5 mM MgCl2, 10% dimethyl sulfoxide, 1.25 mM of each dNTP, and 150 pmol of each primer.


Fig. 1. Map of a 3-kilobase pair fragment containing S. lividans rho gene. The coordinates of the degenerate primers used to amplify rho by PCR are shown (BamHI sites in primers are underlined, I indicates dITP and the two nucleotides in parentheses shows degeneracy). Broad arrows pointing from the N to the C terminus are the Rho 77 and 72 open reading frames.
[View Larger Version of this Image (15K GIF file)]

Library Screening and DNA Analysis

A PCR-derived DNA fragment of the S. lividans rho gene was gel purified using a Quiex Gel Purification kit (Qiagen) and radioactively labeled with [alpha -32P]dCTP using a random-priming kit from Boehringer Mannheim. This probe was used to screen (by colony hybridization) a library of S. lividans ZX7 in cosmid pFD666 (13). The region of the recombinant cosmid DNA identified by the probe was subcloned into pUC18 and restriction endonuclease mapped. Various fragments were subcloned into M13 and sequenced by the dideoxy method using a Sequenase 2.0 kit (Amersham) with deaza-GTP mixture and dITPs to resolve compressions. Sequencing was completed on both strands and across all restriction sites. Sequence assembly and comparison were performed with the GCG package (14) and data base searches used the Blast server (15).

Overexpression of Rho in E. coli

Rho 77 was overexpressed in E. coli fused to an N-terminal hexahistidine-tag. The N-terminal GTG codon of Rho 77 was changed to an ATG start codon with the creation of an in-frame N-terminal NdeI site (underlined) by PCR-mediated mutagenesis with the oligo NDEV1 of sequence 5'-GGAAGGACCC<UNL>CATATG</UNL>AGCGACACCACCGATCTG. This was accomplished by subcloning the N-terminal region of the gene on a 423-bp PstI fragment (Fig. 1) into M13mp18. PCR between oligo NDEV1 and the forward universal primer with Taq polymerase was used to create the NdeI site. The mutagenized, NdeI-PstI cut, N-terminal fragment was then assembled by ligation with the rest of the rho gene (C-terminal PstI-BamHI fragment, Fig. 1) in the His-tag expression vector pET15b (Novagen). The fidelity of PCR was checked by sequencing the N-terminal region after subcloning into M13mp18. A similar strategy was used to overexpress Rho 72 but used the mutagenic oligo NDEM43 (5'-GTACCGGCCTCGAG<UNL>CATATG</UNL>GTGCTGGCCGAG) with translational fusion of the His-tag and thrombin site to Met43 (Fig. 2), removing a KpnI site (Fig. 1) and effectively deleting the first 42 amino acids of Rho 77. Overexpression of Rho 72 and 77 with isopropyl-1-thio-beta -D-galactopyranoside induction in E. coli BL21 (DE3) plysS host cells (Novagen), cell lysis by T7 lysozyme, and His-tag purification of proteins and removal of the His-tag with thrombin protease were all as described by Novagen (16). Expression of Rho and purity were monitored by PAGE (17) and storage of the protein was at -20 °C after dialysis into TEDG50 buffer (18).


Fig. 2.

Multiple sequence alignment of the S. lividans Rho 77 (slirho) with Rho from B. subtilis (bsurho), E. coli (ecorho), M. leprae (mlerho), and M. luteus (mlurho), accession numbers are given in Table I. RNP-1, RNA binding motif, ATPase A/B motifs are boxed for all species. The possible Met43 and Val44 start codons of Rho 72 are boxed in the S. lividans Rho. #: residue conserved in all known Rho analogues, those shown and also Rho from Borrelia burgdorferi (L07656) Pseudomonas fluorescens (L27278), Chromatium vinosum (L27275), Thermotoga maratima (L27279) Neisseria gonhorrhoeae (Z21790), Haemophilus influenzae (925198), Deinocooccus radiodurans (L27276), and Salmonella typhimurium (P26980). *, residue conserved in slirho, mlerho, and mlurho but not universally in Rho analogues. Arrows show the limits of the N-terminal RNA binding domain and the C-terminal ATPase domain of E. coli Rho. The small intervening region is the connector domain. The S. lividans Rho sequence has been deposited in the EMBL data base under accession number X95444[GenBank].


[View Larger Version of this Image (35K GIF file)]

Coupled ATPase Assays

Preliminary assessment of RNA-dependent ATPase activity used the coupled assay of Mori et al. (19). Samples of Rho were incubated at 20 °C in assay buffer (10 mM MgCl2, 40 mM Tris, pH 7.5, 50 mM KCl, 0.1 mM dithiothreitol, 10% (w/v) glycerol, 10 units/ml each of pyruvate kinase and lactate dehydrogenase (both Sigma), 0.2 mM ATP, 0.2 mM phosphoenolypyruvate, and 0.2 mM NADH). NADH oxidation was monitored by the decrease in the O.D. at 340 nm using a Beckman spectrophotometer. The reaction was started by the addition of homopolymeric nucleic acid (oligo(C), poly(C), poly(G), poly(U), and poly(A), Pharmacia, average length at least 180 nucleotides).

Direct ATPase Assays with [gamma -32P]ATP

This method is an adaptation of that of Brennan et al. (20). Rho (approximately 5-10 ng) was incubated in assay buffer (10 mM MgCl2, 40 mM Tris, pH 7.5, 50 mM KCl, 0.1 mM dithiothreitol, 10% (w/v) glycerol, 2 mM [gamma -32P]ATP at 0.5 µCi/µmol specific activity) in 20-µl aliquots at 20 °C, with and without 20 µg/ml homopolymeric RNA, and heparin (Sigma) or rifampicin (Sigma) as appropriate. Samples of 1 µl were spotted onto polyethyleneimine-cellulose TLC plates (Sigma), air dried, and the ATP resolved from phosphate by chromatography in 0.35 M KH2PO4, pH 3.4, with the hydrolysis of ATP quantified using a Fujisawa PhosphorImager.

Direct NTPase Assays with Malachite Green

This method is a modification of that of Hess and Derr (21) for inorganic phosphate adapted to assay NTP hydrolysis, a variant of which has been used to assay activity of Rho from Micrococcus luteus (22). Rho was incubated at 20 °C in 10 mM MgCl2, 40 mM Tris, pH 7.5, 50 mM KCl, 0.1 mM dithiothreitol, 10% (w/v) glycerol with 20 µg/ml poly(C) RNA and from 50 µM to 1 mM of the appropriate NTP for 20 min in a total reaction volume of 200 µl. The reaction was terminated by addition of 800 µl of acidic malachite green solution (0.15% (w/v) malachite green, 0.51% (w/v) ammonium molybdate in 0.5 N HCl, prefiltered through Whatman No. 1 paper). The increase in the OD660 was measured using a spectrophotometer and the amount of phosphate released from the NTP used was calculated using a standard curve prepared with KH2PO4. Apparent Km values were calculated from Lineweaver-Burk plots by linear regression analysis.


RESULTS

Detection and Isolation of the rho Gene

A PCR product of approximately 530 bp was amplified from genomic DNA from Streptomyces ambofaciens, S. lividans ZX7 and Streptomyces coelicolor 1147 and J1501 with primer annealing performed at 50 °C. At an annealing temperature of 55 °C, the 530-bp product was amplified from S. coelicolor 1147 and J1501 but not S. lividans ZX7 DNA. Amplification required both primers and genomic DNA. Southern blotting at high stringency (washes at 65 °C, 0.1 × SSC) showed the PCR products from each species to be closely related, suggesting that a rho analogue is widely distributed in streptomycetes. The S. lividans PCR product was used to isolate four cosmids from a S. lividans ZX7 library. Restriction digests with BamHI suggested that all four cosmids were derived from an overlapping region of the genome. Southern blotting with the PCR product as a probe localized rho to a 3-kilobase pair BamHI fragment both on a digest of genomic DNA and the cosmid clones (data not shown).

Sequence Analysis

The 3-kilobase pair BamHI fragment (EMBL accession no. X95444[GenBank]) was found to contain a single open reading frame with a strong similarity to the enteric rho gene. The open reading frame encoding Rho 77 (707 residues, 77 kDa, Fig. 2) is preceded by the sequence <UNL>G</UNL>G<UNL>AAGGA</UNL>CCCTTCGTG with the GTG translation initiation codon downstream of a plausible RBS (23). An N terminally truncated in-frame, 72-kDa protein (665 residues from Met43, Fig. 2) may also be translated. The N-terminal region of Rho 72 had the sequence <UNL>GAGG</UNL>GCATGGTG with a putative RBS upstream of ATG/Met43 and/or GTG/Val44 initiation codons (Fig. 2, alignment positions 44 and 45, respectively). The BESTFIT analysis between the S. lividans Rho and others is summarized in Table I, with Rho factors from the GC-rich, Gram-positive Mycobacterium leprae and M. luteus the most closely related.

Table I.

Summary of homology between Rho 77 and related proteins using the GCG program BESTFIT to calculate percentage identity (% I) and similarity (% S)

Accession numbers are for GenBank/EMBL.
Polypeptide Accession % I % S Ref.

Bacillus subtilis Rho M97678 50.6 71.3 5
Escherichia coli Rho J01674 52.5 73.1 25
Micrococcus luteus Rho L27277 57.1 73.8 22
Mycobacterium leprae Rho U15186_20 59.4 75.2 Genome Therapeutics Corp.
Yersinia pestis YscN U02499 27.0 51.4 26
Saccharopolyspora erythrae ErmE X51891 24.6 45.1 24

The N-terminal portion of the streptomycete Rho, which is in part aligned with the RNA-binding domain of the E. coli Rho (Fig. 2), was unusual. The most striking atypical feature was a region of 228 mainly hydrophilic or neutral residues from Ala-78 to Asn-326 (alignment positions 79 to 340). While absent from most Rho proteins, Rho from the GC-rich Gram-positive bacteria M. luteus and M. leprae had an analogous hydrophilic region, but the size and primary sequence were not highly conserved. This feature is not peculiar to all the Gram-positive bacteria, the Bacillus subtilis Rho lacks any such sequence. The hydrophilic region is similar to parts of other RNA-binding proteins including the C terminus of the ErmE ribosomal methyltransferase from Saccharopolyspora erythrae (24). A BESTFIT between these two polypeptides largely aligns the N terminus of Rho with the C terminus of ErmE (Table I and data not shown).

As with all other Rho factors, an RNP-1 RNA-binding motif can be identified (residues 342-348, alignment position 358-364). The region flanking this motif appears to be specific to the GC-rich Gram-positive bacteria, particularly DDVXXPVAGILD at alignment position 342-353 (residues 328-339). In addition to this major feature, a minor region of 3-12 additional residues was also present only in the GC-rich Gram-positive bacteria (alignment positions 407-418, Fig. 2).

The sequence of the ATPase domain was highly conserved and included the ATPase A and B motifs and regions characteristic of Rho (Fig. 2). The ATPase A ATP/GTP-binding site of Rho 77 had a threonine rather than alanine as residue 462 (alignment position 492), unusual for Rho (6). Outside the Rho family the best match was to ATPases implicated in energizing the export of proteins involved in virulence, such as YscN from Yersinia pestis (Table I).

Within 50 bp downstream of the TGA stop codon was an inverted repeat with the potential to form a stable RNA hairpin (Delta G = -21.7 kJ/mol), possibly a Rho-independent transcriptional terminator (data not shown).

Overexpression of Rho 72 and 77 in E. coli

Optimal expression of Rho 72 and 77 occurred 1.5 to 2.5 h after isopropyl-1-thio-beta -D-galactopyranoside induction with both attaining up to 10% of total cellular protein. Including the 2 kDa of the hexahistidine tag and associated residues, the sizes predicted were 74 and 79 kDa, respectively. Both polypeptides had PAGE mobility consistent with 85-90-kDa proteins, as estimated using Sigma VIh markers. Purification by nickel-agarose resulted in >90% pure protein as judged by Coomassie Blue-stained SDS-acrylamide gels.

RNA-dependent ATPase Activity

In the absence of RNA, the coupled assay did not detect ATPase activity in preparations of Rho 77. Homopolymeric C, U, and A RNAs were effective in stimulating ATP hydrolysis by Rho 77 while poly(G) was completely inert (Table II). Oligo(C) DNA did not stimulate ATPase activity (Table II) nor did single-stranded M13mp18 DNA (data not shown). The apparent Km value for poly(C)-stimulated ATPase activity (average length 284 nucleotides) was 0.5 µg/ml using the malachite assay. Rho 72 activity was generally similar to Rho 77 (data not shown).

Table II.

Stimulation of Rho 77 ATPase activity (nmol of ATP hydrolyzed/µg Rho/min, ±S.D.) with 20 µg/ml homopolymeric RNA or DNA measured using the indirect assay. Activity normalized to poly(C) stimulation is shown for poly(U) and poly(A) RNA


Nucleic acid ATPase activity Ratio

None <0.01
rC 3.60  ± 0.54 1.00
U 1.51  ± 0.11 0.42
rA 1.02  ± 0.13 0.28
rG <0.01
dC <0.01

Rho 77 was not only an RNA-dependent ATPase but could also hydrolyze GTP, CTP, and UTP, as demonstrated by the release of inorganic phosphate from these compounds. Apparent Km values of Rho 77 (Table III) showed that GTP and then ATP have the lowest Km values followed by UTP. At millimolar CTP concentrations, phosphate contamination gave an unacceptably high background. Along with the particularly low rates of hydrolysis of CTP this made determination of an accurate Km for CTP (>2 mM) impossible. Rho 72 as an NTPase had apparent Km values that were indistinguishable from Rho 77 (data not shown).

Table III.

Apparent Km values (mM) for NTPs for Rho 77 compared to literature values for the E. coli Rho (27)


NTP Rho 77 E. coli Rho

ATP 0.17 0.009
CTP >2.0 0.04
GTP 0.13 0.06
UTP 1.1 0.15

RNA-dependent hydrolysis of ATP could also be demonstrated using a radioactive assay (Table IV). This was performed using higher concentrations of ATP (2 mM) than the coupled assay which partly accounts for the higher rates of hydrolysis. Rifampicin is an inhibitor of initiation of RNA polymerase. Any effect of rifampicin on Rho was assayed by the direct radioactive method because rifampicin was too intensely pigmented for the spectrophotometric assays. Rho 77 was not inhibited by rifampicin (Table IV) which makes it a suitable agent for blocking the reinitiation by RNA polymerase in Rho termination assays. Heparin is used in a similar fashion to rifampicin, but the ATPase activity of Rho 77 was completely inhibited by 100 µg/ml heparin in the direct assay (Table III). This was confirmed using the malachite ATPase assay: only 0.2 µg/ml heparin is required to reduce the ATPase activity of Rho 77 by 50%, when stimulated by either 2 or 20 µg/ml poly(C) RNA (Fig. 3A). Bicyclomycin also inhibited Rho 77 (Fig. 3B) with as little as 7 µM sufficient to reduce the RNA-dependent ATPase activity by 50%. The same sample of bicyclomycin, at a concentration of 75 µg/ml, inhibited growth of E. coli DH5alpha on L-agar plates at 37 °C. In contrast, S. lividans 1326 grew on on soya-mannitol agar plates with 600 µg/ml bicyclomycin, although above 200 µg/ml bicyclomycin delayed the development of aerial mycelia by several days at 25 °C (data not shown). Similar results to S. lividans were obtained for S. coelicolor A3(2) 1980 on R2YE medium, and bicyclomycin also reduced the production of the blue-pigmented antibiotic actinorhodin.

Table IV.

Effect of inhibitors of the RNA polymerase on the RNA-dependent ATPase activity of Rho 77, measured using radioactive method with 2 mM ATP and 100 µg/ml poly(C) RNA

Rates of hydrolysis are nmol ATP hydrolyzed/µg Rho/min (±S.D.). No activity was detected in the absence of RNA.
Activity

Control 7.6  ± 0.8
Rifampicin (2 mg/ml) 6.4  ± 0.7
Heparin (100 µg/ml) <0.1


Fig. 3. Inhibition of ATPase activity of Rho 77, as measured by the malachite green assay with 0.5 mM ATP. A, with 2 µg/ml (open circle ) or 20 µg/ml (bullet ) poly(C) RNA in the presence of heparin. B, with 2 µg/ml poly(C) RNA and in the presence of bicyclomycin.
[View Larger Version of this Image (9K GIF file)]


DISCUSSION

The deduced gene product of Rho from S. lividans shows certain sequence characteristics in the RNA-binding domain that appear peculiar to the GC-rich Gram-positive bacteria. Most notable was a predominantly hydrophilic region of 228 residues, but a putative DDVXXPVAGILD motif and a second minor insert were also characteristic. Within the GC-rich Gram-positive bacteria the sequence and extent of the additional hydrophilic region was surprisingly variable. Apart from an absence of hydrophobic residues, there appears to be few evolutionary constraints. The hydrophilic sequence of the S. lividans Rho resembles regions common to a number of RNA-binding proteins including the C terminus of the ErmE ribosomal methyltransferase. Such a region would be expected to form an unstructured random coil (24). An analogous hydrophilic region is found in the human U1A RNA-binding protein (data not shown) and is known to result in abberent mobility by PAGE (28). The latter observation may explain why Rho 72 and 77 run as if they were larger proteins, something which is also true of the M. luteus Rho (22). An RNP-1 RNA-binding motif was found in the RNA-binding domain. This feature is common to all Rho factors although the RNP-1 motif from the GC-rich Gram-positive bacteria was somewhat distinctive. The ATPase domain of the S. lividans Rho was highly conserved, compared to the RNA-binding domain, and contained both ATPase A and B motifs as well as regions characteristic of Rho-ATPases.

On the basis of alignment with the N-terminal regions of the M. luteus Rho we suggest Rho 77 is expressed in S. lividans. The truncated, in-frame Rho 72 was found to have a possible ribosomal-binding site upstream of the adjacent ATG and GTG start codons. As N terminally distinct isoforms are sometimes found in actinomycete transcriptional regulators, it cannot be excluded that Rho 72 is also expressed. The streptomycete transcriptional regulatory gene tipA (29) and the repressor locus of actinophage øC31 both express such truncations (30).

Rho 77 had RNA-dependent ATPase activity, a property of Rho factors as well as some other helicases. The specificity of Rho 77 for polymeric RNA was far less biased toward poly(C) RNA than Rho from E. coli. Mori and co-workers (19) reported that poly(U) RNA was more than an order of magnitude less effective than poly(C) RNA in stimulating the ATPase activity of E. coli Rho, and did not detect activity with poly(A) RNA. They used a similar method to the results in Table II, which demonstrated that poly(A) RNA was only 4-fold less effective than poly(C). The RNA activation of ATPase activity of Rho 77 resembles mutants of the E. coli Rho more closely than the wild type, for example Rho-Ile323 (19), but no mutant enteric Rho has as broad a specificity as Rho 77. Effective poly(U/A) activation of the Rho 77 ATPase may indicate an adaptation in an organism which has an extreme GC-rich bias. The S. lividans Rho presumably must select termination sites from RNA in which cytosine-rich RNA tracts will be common. While interfering secondary structure may also be more frequent in GC-rich RNA, it is unlikely that this is sufficient to exclude a Rho factor of specificity similar to E. coli from inappropriate sites. Nowatzke and Richardson (22) have found a similarly broad RNA-dependent ATPase activity for Rho purified from M. luteus, so this appears to be a general adaptation of the GC-rich Gram-positive bacteria. The ATPase activity of Rho 77 was not stimulated by poly(G) RNA as a cofactor, also the case with the enteric Rho (27, 34). This is unsurprising, given the highly ordered secondary structure adopted by poly(G) RNA in solution which is likely to preclude Rho 77 from binding (34). Stimulation of ATPase activity with homopolymeric RNAs does not predict the sequence of a Rho-dependent terminator, but it does suggest that recognition of U- and A-rich RNA elements are more important to the GC-rich Gram-positive Rho factors than in E. coli. Defining the ability of an RNA-binding protein to select a particular target RNA is an important goal. Establishing the basis for the diversity of the interaction of Rho from different eubacteria with RNA is likely to enhance our understanding of RNA recognition by proteins generally and Rho function specifically.

The NTPase activities of Rho 77 also differed from the enteric Rho and deletion of the N terminus to express Rho 72 made little difference. The S. lividans Rho was primarily a GTPase/ATPase, both on the basis of Km (Table III) and rate of hydrolysis (data not shown). As little is known about NTP metabolism in streptomycetes, the significance of the higher NTP Km values of Rho 77 compared to the E. coli Rho is unclear. The Rho family may prove a useful group of proteins to approach the question of recognition and hydrolysis of specific NTPs. Mutants altering the preference of the E. coli Rho for NTPs have not been found but this may be because the ATPase activity alone is most commonly assayed.

The poly(C)-dependent ATPase activity of Rho 77 was sensitive to heparin. This was a surprising result given the insensitivity of the E. coli Rho poly(C)-dependent ATPase activity to concentrations as high as 1 mg/ml (27), although stimulation of the enteric Rho by mRNA is heparin sensitive (31). If heparin is acting as a nucleic acid analogue in this experiment, then streptomycete Rho must interact with poly(C) RNA in a different way to the enteric Rho. Inhibition of Rho 77 by heparin did not display simple competitive kinetics with poly(C) RNA (Fig. 3A and data not shown) and the nature of the interaction is unclear.

Bicyclomycin, a known inhibitor of the RNA-dependent ATPase activity of the E. coli Rho, was also effective against the streptomycete Rho at a similar concentration to that required to inhibit the enteric Rho (32). Bicyclomycin retarded the sporulation of S. lividans and S. coelicolor A3(2), possibly a consequence of inhibiting Rho in vivo. This is interesting given that the Gram-positive bacteria, unlike enteric bacteria, are generally resistant to this antibiotic (33). Bicyclomycin may be inactivated or excluded in some fashion or the Gram-positive Rho may be inessential. Indeed, Quirk et al. (5) have shown that the B. subtilis rho gene can be disrupted.


FOOTNOTES

*   This work was supported by Medical Research Council Grant G9224695MB and funding from the University of Nottingham. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence should be addressed: Dept. of Life Science, University Park, Nottingham University, Nottingham, NG7 2RD, UK. Fax: 0115-951-3251; E-mail: plzcji{at}pln1.life.nottingham.ac.uk.
   Present address: Dept. of Bioscience and Biotechnology, Strathclyde University, George St., Glasgow, G1 1QW, UK.
1   The abbreviations used are: PCR, polymerase chain reaction; bp, base pair(s); PAGE, polyacrylamide gel electrophoresis; NTP, nucleoside triphosphate; RBS, ribosome-binding site; poly(A), polyadenylate, poly(C), polycytidylate; poly(G), polyguanidylate; poly(U), polyuridylate RNA.

Acknowledgments

We thank Ranjan Prasad for access to the ZX7 library, John Richardson, Tim Opperman, and Bill Nowatzke for unpublished results, John Richardson for constructive criticism, John Peberdy for laboratory space, the Genome Therapeutics Corp., Waltham, MA, for permission to show the mycobacterial Rho sequence, and Fujisawa Pharmaceutical Co. for samples of bicyclomycin.


REFERENCES

  1. Richardson, J. P. (1993) Crit. Rev. Biochem. Mol. Biol. 28, 1-30 [Medline] [Order article via Infotrieve]
  2. Platt, T. (1994) Mol. Microbiol. 11, 983-990 [CrossRef][Medline] [Order article via Infotrieve]
  3. Brennan, C. A., Dombroski, A. J., Platt, T. (1987) Cell 48, 945-952 [CrossRef][Medline] [Order article via Infotrieve]
  4. Ruteshouser, E. C., Richardson, J. P. (1989) J. Mol. Biol. 208, 23-43 [CrossRef][Medline] [Order article via Infotrieve]
  5. Quirk, P. G., Dunkley, E. A., Jr., Lee, P., Krulwich, T. A. (1993) J. Bacteriol. 175, 647-654 [Abstract/Free Full Text]
  6. Opperman, T., Richardson, J. P. (1994) J. Bacteriol. 176, 5033-5043 [Abstract/Free Full Text]
  7. Biville, F., Guiso, N. (1985) J. Gen. Microbiol. 131, 2953-2960 [Medline] [Order article via Infotrieve]
  8. Fraser, C. M., Gocayne, J. D., White, O., Adams, M. D., Clayton, R. A., Fleischmann, R. D., Bult, C. J., Kerlavage, A. R., Sutton, G., Kelley, J. M., Fritchman, J. L., Weidman, J. F., Small, K. V., Sandusky, M., Fuhrmann, J., Nguyen, D., Utterback, T. R., Saudek, D. M., Phillips, C. A., Merrick, J. M., Tomb, J-F., Dougherty, B. A., Bott, K. F., Hu, P-C., Lucier, T. S., Peterson, S. N., Smith, H. O., Hutchison, C. A., III, Venter, J. C. (1995) Science 270, 397-403 [Abstract/Free Full Text]
  9. Sambrook, J., Fritsch, E. F., Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  10. Hopwood, D. A., Bibb, M. J., Chater, K. F., Kieser, T., Bruton, C. J., Kieser, H. M., Lydiate, D. J., Smith, C. P. Ward, J. M., and Schrempf, H. (1985) Genetic Manipulation of Streptomyces: A Laboratory Manual, The John Innes Foundation, Norwich, United Kingdom
  11. Hunter, I. S. (1989) DNA Cloning: A Practical Approach (Glover, D. M., eds) , Vol I, p. 19, IRL Press, Oxford
  12. Kieser, H. M., Kieser, T., Hopwood, D. A. (1992) J. Bacteriol. 174, 5496-5507 [Abstract/Free Full Text]
  13. Denis, F., Brzezinski, R. (1992) Gene (Amst.) 111, 115-118 [CrossRef][Medline] [Order article via Infotrieve]
  14. Devereux, J., Haeberli, P., Smithies, O. (1984) Nucleic Acids Res. 12, 387-395
  15. Altshul, S. F., Gish, W., Miller, W., Myers, E. W., Lipman, D. (1990) J. Mol. Biol. 215, 403-410 [CrossRef][Medline] [Order article via Infotrieve]
  16. Novagen Inc. (1995) pET System Manual, 6th Edition, Novagen, Inc., Madison, WI
  17. Laemmli, U. K. (1970) Nature 227, 680-685 [CrossRef][Medline] [Order article via Infotrieve]
  18. Modrak, D., Richardson, J. P. (1994) Biochemistry 33, 8292-8299 [CrossRef][Medline] [Order article via Infotrieve]
  19. Mori, H., Imai, M., Shigesada, K. (1989) J. Mol. Biol. 210, 39-49 [CrossRef][Medline] [Order article via Infotrieve]
  20. Brennan, C. A., Steinmetz, E. J., Spear, P., Platt, T. (1990) J. Biol. Chem. 265, 5440-5447 [Abstract/Free Full Text]
  21. Hess, H. H., Derr, J. E. (1975) Anal. Biochem. 63, 607-613 [CrossRef][Medline] [Order article via Infotrieve]
  22. Nowatzke, W. L., Richardson, J. P. (1996) J. Biol. Chem. 271, 742-747 [Abstract/Free Full Text]
  23. Bibb, M. J., Bibb, M. J., Ward, J. M., Cohen, S. N. (1985) Mol. Gen. Genet. 199, 26-36 [CrossRef][Medline] [Order article via Infotrieve]
  24. Dhillon, N., and Leadlay, P. F. (1990) FEBS Micro. Lett. 262, 189-193
  25. Pinkham, J. L., Platt, T. (1983) Nucleic Acids Res. 11, 3531-3545 [Abstract/Free Full Text]
  26. Woestyn, S., Allaoui, A., Wattiau, P., Cornelis, G. R. (1994) J. Bacteriol. 176, 1561-1569 [Abstract/Free Full Text]
  27. Lowery, C., Richardson, J. P. (1977) J. Biol. Chem. 252, 1375-1380 [Abstract/Free Full Text]
  28. Kiledjian, M., Dreyfuss, G. (1992) EMBO J. 11, 2655-2664 [Medline] [Order article via Infotrieve]
  29. Holmes, D. J., Caso, J. L., Thompson, C. J. (1993) EMBO J. 12, 3183-3191 [Medline] [Order article via Infotrieve]
  30. Smith, M. C. M., Owen, C. E. (1991) Mol. Microbiol. 5, 2833-2844 [Medline] [Order article via Infotrieve]
  31. Bektesh, S. L., Richardson, J. P. (1981) Biochim. Biophys. Acta 655, 96-101 [Medline] [Order article via Infotrieve]
  32. Park, H. G., Zhang, X. D., Moon, H. S., Zwiefka, A., Cox, K., Gaskell, S. J., Widger, W. R., Kohn, H. (1995) Arch. Biochem. Biophys. 323, 447-454 [CrossRef][Medline] [Order article via Infotrieve]
  33. Nishida, M. (1972) J. Antibiot. 25, 582-593
  34. Tsurushita, N., Shigesada, M., Imai, M. (1989) J. Mol. Biol. 210, 23-37 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
V. C. S. Italiani and M. V. Marques
The Transcription Termination Factor Rho Is Essential and Autoregulated in Caulobacter crescentus
J. Bacteriol., June 15, 2005; 187(12): 4290 - 4294.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. L. Nowatzke, C. M. Burns, and J. P. Richardson
Function of the Novel Subdomain in the RNA Binding Domain of Transcription Termination Factor Rho from Micrococcus luteus
J. Biol. Chem., January 24, 1997; 272(4): 2207 - 2211.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ingham, C. J.
Right arrow Articles by Smith, M. C.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ingham, C. J.
Right arrow Articles by Smith, M. C.M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.